版本:
中国

RPT-BRIEF-U.S. FDA says Magellan Diagnostics expands recall for leadcare testing systems (June 5)‍​

(Repeats June 5 item to add company ticker)

June 5 U.S. FDA:

* U.S. FDA says Magellan Diagnostics expands recall for leadcare testing systems due to inaccurate test results ‍​

* U.S. FDA says Magellan Diagnostics expands recall for leadcare and leadcare II blood lead testing systems to 7.1 million devices‍​

* U.S. FDA says Magellan Diagnostics expands leadcare plus and ultra testing systems recall to include two additional testing systems

* U.S. FDA says has identified Magellan Diagnostics' recall as a class I recall, the most serious type of recall Source text - (bit.ly/2swUCb7)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐